07/18/2026
Kicking off Day 3 of the American Society of Pain and Neuroscience (ASPN) Annual Meeting with another full day of engaging, interactive sessions focused on the latest advances in neuromodulation.
The energy, collaboration, and scientific discussions at this meeting continue to reinforce why neuromodulation is one of the most rapidly evolving fields in medicine. From innovative technologies to real-world clinical applications, every session offers new insights that can directly translate into better outcomes for our patients.
As someone who has dedicated much of my career to advancing Dorsal Root Ganglion (DRG) stimulation, it’s an honor to share experiences, exchange ideas with colleagues, and contribute to the ongoing evolution of evidence-based neuromodulation. DRG therapy continues to demonstrate its unique value in treating focal, chronic neuropathic pain and expanding the possibilities of personalized pain care.
Grateful to be part of such an outstanding community of clinicians, researchers, and innovators committed to improving patients’ lives.